Patient selection for corneal collagen cross-linking: an updated review

Virgilio Galvis,1–3 Alejandro Tello,1–3 Alvaro I Ortiz,3 Luis C Escaf2 1Centro Oftalmológico Virgilio Galvis, Floridablanca, 2Department of Ophthalmology, Faculty of Health Sciences, Universidad Autónoma de Bucaramanga, Bucaramanga, 3Department of Ophthalmo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Galvis V, Tello A, Ortiz AI, Escaf LC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/4078a343389848afa6e2078086d20810
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Virgilio Galvis,1–3 Alejandro Tello,1–3 Alvaro I Ortiz,3 Luis C Escaf2 1Centro Oftalmológico Virgilio Galvis, Floridablanca, 2Department of Ophthalmology, Faculty of Health Sciences, Universidad Autónoma de Bucaramanga, Bucaramanga, 3Department of Ophthalmology, Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Santander, Colombia Abstract: Corneal cross-linking (CXL) is an option that in the last decade has demonstrated its efficacy and safety in halting the progression of keratoconus (KCN) and other corneal ectasias. Its indication has been extended beyond the classic definition that required evidence of KCN progression, especially in the presence of some risk factors for a possible progression (particularly the younger age). However, the results can be still somewhat variable today. There are several protocols, each with its own advantages and disadvantages. Some predictors of CXL outcome have been identified. We will review the current knowledge on patient selection for CXL, its indications, and options in special cases (such as thin corneas). Keywords: keratoconus, cornea, cross-linking, corneal collagen cross-linking, keratoectasia